Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Medical Marijuana, Inc.'s CEO on Union Tribune Radio Discussing International Cannabis Law Changes, US Cannabis Exports: RSHO and RSHO-X Cannabidiol (CBD) Products
Globe Newswire
First Brazil and Now Mexico, Media Reports Historic Shift in International Cannabis Laws Resulting in New Cannabis-Based Economic Development

SAN DIEGO, Feb. 11, 2016 (GLOBE NEWSWIRE) -- The world has benefited from life-changing discoveries and resulting innovations.  Consumers today would have an uncomfortable time living without innovations to the toothbrush, the lightbulb, telephone, automobile or internet.  One discovery - hemp - has been documented for thousands of years as textiles and for health.  Medical Marijuana, Inc. (OTC Pink:MJNA) is proud to announce its hemp innovations: Real Scientific Hemp Oil™ (RSHO™) and Real Scientific Hemp Oil-X™ (RSHO-X™). 

These all-natural cannabis products contain an abundance of cannabidiol (CBD), a cannabinoid or component of the plant.  RSHO™ and RSHO-X™ are fostering global awareness, education and cannabis law changes permitting its access and consumption. As heard on U-T’s Community Spotlight Radio show, RSHO™ is being imported in Brazil with ANVISA permit and RSHO-X™ is approved for individuals in Mexico with COFEPRIS import permit. 

“It is not often that we witness entire countries initiating sweeping law change,” states Stuart W. Titus, PhD and Chief Executive Officer of Medical Marijuana, Inc. “Such is the case with Mexico and Brazil and cannabis law reform.  These Federal governments have made it possible for more than a combined 360 million people to access RSHO™ and RSHO-X™ CBD as a personal right, once these markets fully develop.”

Marijuana and hemp are cannabis.  What differentiates the plants are the levels of cannabinoids that make up each plant.  Marijuana is cultivated for an abundance of tetrahydrocannabinol (THC), the psychotropic compound, whereas in hemp THC is naturally, virtually non-existent.  In hemp, there is a natural abundance of cannabidiol (CBD) and with MJNA’s proprietary cultivars, these natural products are actively sought out by countries and individuals around the world. 

Dr. Titus spoke about the increase of global cannabis awareness, education and accessibility during a news interview by the U-T Community Spotlight Radio show. For those who would like to learn more about Medical Marijuana, Inc.’s efforts to increase RSHO™ and RSHO-X™ accessibility, click here to listen to the engaging interview

Attention Healthcare Professionals:
Dr. Titus will give a keynote address on CBD at the VII Mexico City World Anti-aging Congress (Congreso Mundial en Medicina Antienvejecimiento AMA Mexico) Saturday, February 13th at 12:30 p.m.  Members of the healthcare community must register for the conference online.  Event details are:

Congreso Mundial en Medicina Antienvejecimiento AMA Mexico
7th Anti-Aging and Regenerative Medicine
Exhibit Space #19 – HempMeds® Mexico
Puebla Privada Jalisco 8
Colonia El Carmen 7200
Tel: +56 80 65 68 or E-mail
Venue: Hotel Fiesta Americana Reforma, Mexico City

For instructions on how to begin the RSHO-XTM import process, contact COFEPRIS for details. For information on RSHO-X™ product availability in Mexico, click here to register with HempMeds® Mexico website at http://www.hempmeds.mx  or to speak with a HempMeds® Mexico representative, contact the customer service department at:
US: 1-866-786-2440
MX: 001-883-786-2440

To date, HempMeds® Brasil has three indications approved for export from the U.S. to Brazil: epilepsy, Parkinson’s disease and chronic pain, with several more serious health conditions expected to be added over the coming quarter.  For information on RSHO™ product availability in Brazil and the import process, contact ANVISA for details.  For information on RSHO™ product availability in Brazil, visit the HempMeds® Brasil website at http://www.hempmeds.com.br 

About HempMeds® Mexico
HempMeds® Mexico is a Mexico-based company, created to provide access to cannabinoid-based products including cannabidiol (CBD) hemp oil products as they become legal in the country of Mexico for the first time. Our Company is a sales, marketing and distribution company. HempMeds® Mexico plans to work directly with the Mexican government to safely and legally provide access to our CBD hemp oil products. HempMeds® Mexico is the first company to legally ship RSHO-XTM CBD hemp oil into Mexico for individuals with a permit. For more information, please review the company’s website at: http://hempmeds.mx/.

About HempMeds Brasil
HempMeds Brasil™ is a corporate affiliated company of Medical Marijuana, Inc. (OTC Pink:MJNA) and is its exclusive distributor of RSHO™. HempMeds Brasil™ offers specialized marketing, sales, customer service, and logistics to supply natural hemp oil rich in CBD to the medical community and families of Brazil. For more information on HempMeds Brasil™ and their all-natural hemp oil products, visit: http://www.hempmeds.com.br. The Company invites the public to get involved in the conversation on the expanding cannabis industry with HempMeds Brasil™ through the Company's social media channels Facebook, Twitter and blog.

About Medical Marijuana Inc.
The mission of Medical Marijuana, Inc. (OTC Pink:MJNA) is to be the premier hemp industry innovator, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company's website at: www.MedicalMarijuanaInc.com.

These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

Medical Marijuana Inc. and HempMeds do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

For further information, please contact:
Public Relations contact:
Andrew Hard
Chief Executive Officer
CMW Media
P. 888-829-0070

Corporate contact:
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)

Primary Logo

 Top of page